Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 39.0 | 51 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 41.0 | 42 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 17.0 | 54 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 31.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 30.0 | 51 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 22.0 | 50 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 48.5 | 42 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 37.0 | 55 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 48.5 | 62 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 45.5 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 20.5 | 58 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-4 | 32.0 | 51 | |
RA2159 | 3 | IL-4 | 18.5 | 60 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-4 | 15.0 | 39 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-4 | 16.0 | 46 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-4 | 20.0 | 47 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-4 | 22.0 | 47 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL-4 | 21.0 | 57 | ||||
RA2159 | 3 | IL-4 | 20.0 | 49 | |||||||
N2586 | 3 | IL-4 | 21.0 | 51 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | IL-4 | 20.5 | 50 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | IL-4 | 18.0 | 62 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | IL-4 | 20.0 | 35 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | IL-4 | 16.0 | 87 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL-4 | 21.0 | 50 |